PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.\', \'Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China.\', \'Tsinghua-Peking Center for Life Sciences, Beijing, China.\', \'Department of Infectious Diseases, Jin Yin-tan Hospital, Wuhan, China.\', \'Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China.\', \'Medial Research Center, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.627844
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33679771
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China.
?:type

Metadata

Anon_0  
expand all